<?xml version="1.0" encoding="UTF-8"?>
<p>Fourth, looking at international collaboration, we observed the USA to be very dominant in all the disease studies (Fig. 
 <xref ref-type="fig" rid="fig7">7</xref>). Looking at China, we found it to be mainly dominant in diseases that were epidemiologically relevant to public health in China, such as SARS, avian influenza, and hepatitis B. When looking at Ebola, which has not been a threat to China for the past 2 decades, we observed a relatively low investment in its research in China. We observed that regarding MERS, we found results similar to those of Sa’ed [
 <xref rid="bib50" ref-type="bibr">50</xref>]. In both studies the top 3 biggest contributors in MERS studies were the USA, China, and Saudi Arabia.
</p>
